AlokSahayMD

Clinical Trials

• Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease Start of enrollment: 2002 Mar 01

  Terminated

  Phase 2, Phase 3

• Parkinson's Research: The Organized Genetics Initiative Start of enrollment: 1998 Aug 01

  Completed

• A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease Start of enrollment: 2005 Nov 01

  Completed

  Phase 3

• Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia Start of enrollment: 2002 Jul 01

  Completed

  Phase 2

• Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's Start of enrollment: 2003 Dec 01

  Completed

  Phase 3

• A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients Start of enrollment: 2006 Nov 01

  Completed

  Phase 4

• Effects of Coenzyme Q10 (CoQ) in Parkinson Disease Start of enrollment: 2008 Dec 01

  Terminated

  Phase 3

• Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease Start of enrollment: 2009 Jul 01

  Completed

  Phase 2

• ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects Start of enrollment: 2009 Jul 01

  Completed

• Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease Start of enrollment: 2009 Dec 01

  Completed

  Phase 4

• Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) Start of enrollment: 2010 Nov 01

  Completed

  Phase 2

• Efficacy of Isradipine in Early Parkinson Disease Start of enrollment: 2014 Nov 01

  Completed

  Phase 3

• Join now to see all